Tiletamine Hcl, Zolazepam Hcl
263 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
263
Total Reports
119
Deaths Reported
4520.0%
Death Rate
Active Ingredients
Tiletamine Hcl, Zolazepam Hcl
Administration Routes
IntramuscularUnknownIntravenousSubcutaneousOtherParenteralOralOphthalmic
Species Affected
Dog 127
Cat 105
Unknown 21
Pig 4
Human 3
Rabbit 1
Guinea Pig 1
Other Birds 1
Most Affected Breeds
Dog (unknown) 51
Cat (unknown) 45
Domestic Shorthair 44
Unknown 25
Retriever - Labrador 12
Shepherd Dog - German 10
Domestic Longhair 9
Chihuahua 4
Rottweiler 4
Pig (unknown) 4
Most Reported Reactions
Lack of efficacy - NOS 126
Unrelated death 67
Death 44
Death by euthanasia 39
Cardiac arrest 18
Respiratory arrest 15
Recovery prolonged 14
Apnoea 12
Cyanosis 12
Hyperthermia 11
Aggression 7
Appearance, Abnormal 7
Outcome Breakdown
Recovered/Normal
112 (45.0%)
Euthanized
71 (28.5%)
Died
48 (19.3%)
Outcome Unknown
15 (6.0%)
Ongoing
2 (0.8%)
Recovered with Sequela
1 (0.4%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.